Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility. - Wikidata - awgldk - TriplyDB

Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.

Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.

http://www.wikidata.org/entity/Q41708431

about

Treatment for recurrent vulvovaginal candidiasis (thrush)Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective Fluconazole pharmacokinetics and safety in premature infants Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans.Pharmacokinetics of antifungal agents in children.Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.Tissue penetration of antifungal agents.Pediatric antifungal agents.The use of antifungal therapy in neonatal intensive care.Antifungal therapy in children: an update.Antifungal agents in current pediatric practice.Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.Review of some pharmacokinetic and pharmacodynamic properties of anti-infective medicines administered to the koala (Phascolarctos cinereus).Acute adrenal failure associated with fluconazole after administration of high-dose cyclophosphamide.Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis

P2860

Q24234856-B514689B-D9E3-4BD8-AE41-FD3CAC0623B0 Q27009221-623F4FE7-23DA-4D52-BF2A-0075AE0E70A1 Q27014816-CAE84A40-D3DA-4AB4-BD7C-9DC5AE0B0B72 Q33981330-4514CEB1-B97D-4B2E-A6A8-020EB2E5F7B9 Q36163345-D0AE53A5-E576-4DF8-91E0-91D612FA6F46 Q36521993-C5787288-5FD3-42D1-92C2-F8A5F9E78C96 Q37247728-614AD853-B630-4D18-8484-49BBB0CB95D5 Q37544911-9CB50CBB-A756-4156-A9D4-CD0A7AC0710F Q37594515-AF535119-6BCD-46DF-8767-2493BE2B5412 Q37985070-59CDFFC0-BD8B-4BD2-88E5-FFA9499F5068 Q38015090-60408878-8E3C-45C9-81D4-E26433E20594 Q38101520-31BB8DED-C9BE-45B1-9514-691EF73EC3BB Q38215682-526F3972-0CF5-4DA5-9EFE-1E4E16AE78F2 Q39432406-6AAA7BEF-731B-4435-8F43-EFD205A7D94C Q43560607-81AE4188-D8CB-4B5C-8B12-EEA6B7471170 Q58698762-2F62517C-5ADF-41D9-BB00-30E2CD33ADF7

P2860

Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.

http://www.wikidata.org/entity/Q41708431

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.

@en

type

label

Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.

@en

prefLabel

Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.

@en

P1433

Q41708431-1D2ECAD1-06AB-407F-9DF9-E04721BC1FEB

P1476

Q41708431-DD6D6E6E-1DC9-445A-A8E5-DBB61FB22E28

P2093

Q41708431-7D92060F-5398-4791-A3A1-2EC7E0771937

Q41708431-8FECC639-4E1F-40E9-9791-DE0CB46DC550

Q41708431-98A77DF2-4A15-47FB-BDFD-E25D9254F360

Q41708431-B3009FFB-D031-4B5A-91EB-C5EA4C50031A

Q41708431-E07CF08D-178B-4D2C-8A62-BF2443BD52B4

P2860

Q41708431-4937E153-CF7C-415C-AFB7-C49BF5130D42

Q41708431-7B779A8E-5447-4B1F-B158-EFE0FC5E6745

Q41708431-82B93EDD-CCAC-4307-8ECC-8DC8157D4F45

Q41708431-880782CD-15E3-4B55-9004-27D38DBEEF33

Q41708431-A83E72ED-590D-4B0A-9E0E-4B878D7F9136

Q41708431-BBEAFE9A-7E40-4EE2-ADCC-970A02AE58D2

Q41708431-D8D60A27-0628-4390-990C-7644B257231B

Q41708431-F443F61F-9071-40A4-BB86-702DDC393217

P304

Q41708431-CDB0FFAD-9EDF-48E7-81F3-7A62514E2136

P31

Q41708431-5108d773-64af-415e-b281-0a046380bbf5

Q41708431-94E4777D-EC7C-477D-BA35-9C8604238ACE

P356

Q41708431-7AD6A95B-57FA-454C-BDB9-112459E7038E

P433

Q41708431-85924334-A99A-46AC-ABCA-EC9F2C87FD11

P478

Q41708431-772BA71E-133C-4445-8E85-7C0ED90C58EA

P577

Q41708431-1A69E09A-02AD-40F9-A5A6-177423F3FF9F

P698

Q41708431-6C70390B-EC24-43DF-AAB9-D7E82625386D

P356

J.1439-0507.1997.TB00230.X

P1433

P1476

Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility.

@en

P2093

Laufen H

http://www.w3.org/2001/XMLSchema#string

Schmalreck AF

http://www.w3.org/2001/XMLSchema#string

Wildfeuer A

http://www.w3.org/2001/XMLSchema#string

Yeates RA

http://www.w3.org/2001/XMLSchema#string

Zimmermann T

http://www.w3.org/2001/XMLSchema#string

P2860

Sputum levels of fluconazole in humans.

Fluconazole penetration in cerebral parenchyma in humans at steady state

Fluconazole levels in plasma and vaginal secretions of patients after a 150-milligram single oral dose and rate of eradication of infection in vaginal candidiasis.

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans.

High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group.

High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS.

Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A randomized trial.

P304

259-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1439-0507.1997.TB00230.X

http://www.w3.org/2001/XMLSchema#string

P433

7-8

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

1997-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9476508

http://www.w3.org/2001/XMLSchema#string